Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atrotech is a Finnish medical device company focused on functional electrical stimulation for respiratory support. Its flagship commercial product is the Atrostim phrenic nerve stimulator, a diaphragm pacing system used as an alternative to long-term mechanical ventilation in patients with respiratory muscle paralysis or central alveolar hypoventilation. The company appears to operate as a niche medtech manufacturer rather than a drug developer, with expertise in implantable medical devices and associated programming and control systems. In addition to selling Atrostim, Atrotech has indicated that it provides design and manufacturing services related to implantable medical devices for external partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Atrotech.